| Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
34,419 | 31,585 | 32,189 | 28,327 | 23,817 | 20,503 | 0 | 0 | 0 |
General and administrative | ||||||||
19,459 | 12,572 | 12,688 | 11,694 | 9,047 | 7,001 | 0 | 0 | 0 |
Total operating expenses | ||||||||
53,878 | 44,157 | 37,088 | 30,443 | 0 | - | 0 | 0 | - |
Other income (expense): | ||||||||
Interest and other income | ||||||||
3,602 | 2,862 | 1,942 | 1,146 | 0 | - | 0 | 0 | - |
Other income (expense), net | ||||||||
10,979 | 3,993 | -1,792 | -5,923 | 0 | - | 0 | 0 | - |
Total other income (expense), net | ||||||||
14,581 | 6,855 | 2,404 | -4,724 | -7,672 | -2,146 | 0 | 0 | 0 |
Loss before provision for income taxes | ||||||||
-39,297 | -37,302 | -42,473 | -44,745 | -40,536 | -29,650 | 0 | 0 | 0 |
Provision for income taxes | ||||||||
-401 | -440 | -214 | -297 | 0 | 0 | 0 | - | - |
Net loss | ||||||||
-38,896 | -36,862 | -42,259 | -44,448 | -40,573 | -29,687 | 0 | 0 | 0 |
Other comprehensive income (loss): | ||||||||
Foreign currency translation adjustment | ||||||||
-13,091 | -6,745 | -1,132 | 3,158 | 0 | - | 0 | 0 | - |
Change in net unrealized holding gains (losses) on available for sale securities | ||||||||
0 | - | 0 | 0 | - | - | - | - | - |
Total other comprehensive loss | ||||||||
-51,164 | -41,526 | -35,503 | -27,794 | 0 | - | 0 | 0 | - |
Basic and diluted net loss per ordinary share | ||||||||
-0.50 | -0.26 | -0.21 | -0.29 | -0.52 | -0.50 | -0.38 | -0.18 | -0.30 |
Weighted average basic and diluted ordinary shares | ||||||||
32,944 | 32 | 28,139 | 28,053 | 27,862 | 27 | 21,514 | 23,688 | 11 |